To evaluate the impact of IDH2 on lung cancer growth in vivo and the therapeutic activity of cisplatin in mice, we performed an animal study using tumor xenografts with A549 cells containing wild-type IDH2 or IDH2 knockdown (stable) via shRNA mediated by a lentiviral vector. Here, IDH2 is linked to lung cancer.